May 14, 2026

UCI Health raises colon cancer awareness on “Dress in Blue Day”

UCI Health joined the national “Dress in Blue Day” campaign on March 10 to raise awareness.

UCI Health

May 13, 2026

Global Review Shows Impact of Exposure to Air Pollution on Cancer Risk and Mortality

A new report released by the Union for International Cancer Control shows that people exposed over the long term to fine particulate matter (PM2.5) (such as vehicle exhaust, wildfires, wood burning) h...

The ASCO Post

May 06, 2026

Colorectal Cancer Treatment During Pregnancy

Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. This article follows the case of a 36-year-old woman diagnosed with CRC while pregnant and highlights considerations around CRC diagnosis and cancer treatment during pregnancy.

Jadpro

April 30, 2026

Can Pesticide Exposure Increase Early-Onset Colorectal Cancer Risk?

“In this analysis, we observed significant differences in epigenetic signatures associated with diet, tobacco, and pesticide exposure. Among the pesticides, a very clear correlation signal stood out b...

The ASCO Post

April 29, 2026

Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer

In a phase Ib/II study (OrigAMI-1) reported in the Journal of Clinical Oncology, Oberstein et al found that the EGFR-MET bispecific antibody amivantamab-vmjw showed activity when used as monotherapy i...

The ASCO Post

April 29, 2026

Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer

In a phase Ib/II study (OrigAMI-1) reported in the Journal of Clinical Oncology, Oberstein et al found that the EGFR-MET bispecific antibody amivantamab-vmjw showed activity when used as monotherapy i...

The ASCO Post

April 29, 2026

Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer

In a phase Ib/II study (OrigAMI-1) reported in the Journal of Clinical Oncology, Oberstein et al found that the EGFR-MET bispecific antibody amivantamab-vmjw showed activity when used as monotherapy i...

The ASCO Post

April 29, 2026

Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer

In a phase Ib/II study (OrigAMI-1) reported in the Journal of Clinical Oncology, Oberstein et al found that the EGFR-MET bispecific antibody amivantamab-vmjw showed activity when used as monotherapy i...

The ASCO Post

April 28, 2026

Proton Therapy in Early-Onset Locally Advanced Rectal Cancer: The Importance of Fertility-Preserving Multimodality Care

The rising incidence and mortality of early-onset colorectal cancer (EOCRC), defined as disease occurring in patients younger than 50, has emerged as a clinically significant trend with implications for screening, diagnosis, and survivorship.

Baptist Health South Florida

April 27, 2026

Educational Disparities in Young-Onset Colorectal Cancer Mortality

A nationwide cross-sectional analysis found that rising colorectal cancer death rates among young adults are largely concentrated among those with lower educational attainment.

The ASCO Post